NOTE 12.  BUSINESS ACQUISITION Bayside Business Solutions, Inc.
Effective July 1, 2015, the Company acquired all of the equity interests of Bayside Business Solutions, an Alabama-based company that provides technology solutions and payment processing services primarily for the financial services industry, for $10,000 paid in cash.
This acquisition was funded using existing operating cash.
The acquisition of Bayside Business Solutions expanded the Company’s presence in commercial lending within the industry.
Management has completed a purchase price allocation of Bayside Business Solutions and its assessment of the fair value of acquired assets and liabilities assumed.
The recognized amounts of identifiable assets acquired and liabilities assumed, based upon their fair values as of July 1, 2015 are set forth below:
## Table 0 ##
The goodwill of $6,099 arising from this acquisition consists largely of the growth potential, synergies and economies of scale expected from combining the operations of the Company with those of Bayside Business Solutions, together with the value of Bayside Business Solutions’ assembled workforce.
Goodwill from this acquisition has been allocated to our Bank Systems and Services segment.
The goodwill is not expected to be deductible for income tax purposes.
Identifiable intangible assets from this acquisition consist of customer relationships of $3,402, $659 of computer software and other intangible assets of $944.
The weighted average amortization period for acquired customer relationships, acquired computer software, and other intangible assets is 15 years, 5 years, and 20 years, respectively.
Current assets were inclusive of cash acquired of $1,725.
The fair value of current assets acquired included accounts receivable of $178.
The gross amount of receivables was $178, none of which was expected to be uncollectible.
During fiscal year 2016, the Company incurred $55 in costs related to the acquisition of Bayside Business Solutions.
These costs included fees for legal, valuation and other fees.
These costs were included within general and administrative expenses.
The results of Bayside Business Solutions’ operations included in the Company’s consolidated statement of income for the twelve months ended June 30, 2017 included revenue of $6,536 and after-tax net income of $1,307.
For the twelve months ended June 30, 2016, Bayside Business Solutions’ contributed $4,273 to revenue, and after-tax net income of $303.
The accompanying consolidated statements of income do not include any revenues and expenses related to this acquisition prior to the acquisition date.
The impact of this acquisition was considered immaterial to both the current and prior periods of our consolidated financial statements and pro forma financial information has not been provided.
SVB FINANCIAL GROUP AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued) Investments in Entities that Calculate Net Asset Value Per Share FASB guidance over certain fund investments requires that we disclose the fair value of funds, significant investment strategies of the investees, redemption features of the investees, restrictions on the ability to sell investments, estimate of the period of time over which the underlying assets are expected to be liquidated by the investee, and unfunded commitments related to the investments.
Our investments in debt funds and venture capital and private equity fund investments generally cannot be redeemed.
Alternatively, we expect distributions to be received through IPO’s and merger and acquisition (“M&A”) activity of the underlying assets of the fund.
We currently do not have any plans to sell any of these fund investments.
If we decide to sell these investments in the future, the investee fund’s management must approve of the buyer before the sale of the investments can be completed.
The fair values of the fund investments have been estimated using the net asset value per share of the investments, adjusted for any differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example September 30 , for our December 31 consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.
The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of December 31, 2011:
## Table 1 ##
(1) Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds, one of our direct venture funds and one other private equity fund.
These investments represent investments in venture capital and private equity funds that invest primarily in U. S.  and global technology and life sciences companies.
Included in the fair value and unfunded commitments of fund investments under fair value accounting are $534.2 million and $296.4 million, respectively, attributable to noncontrolling interests.
It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.
(2) Other investments within non-marketable securities (equity method accounting) include investments in debt funds and venture capital and private equity fund investments that invest in or lend money to primarily U. S.  and global technology and life sciences companies.
It is estimated that we will receive distributions from the fund investments over the next 10 years, depending on the age of the funds.
(3) Venture capital and private equity fund investments within non-marketable securities (cost method accounting) include investments in venture capital and private equity fund investments that invest primarily in U. S.  and global technology and life sciences companies.
It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of the terms of the funds.
The fair value of our equity warrant assets portfolio is reviewed quarterly.
We value our equity warrant assets using a modified Black-Scholes option pricing model, which incorporates the following significant inputs: An underlying asset value, which is estimated based on current information available, including any information regarding subsequent rounds of funding for the equity issuing the warrant.  ?
Stated strike price, which can be adjusted for certain warrants upon the occurrence of subsequent funding rounds or other future events.  ?
Price volatility or the amount of uncertainty or risk about the magnitude of the changes in the warrant price.
The volatility assumption is based on historical price volatility of publicly traded companies within indices similar in nature to the underlying client companies issuing the warrant.
The actual volatility input is based on the median volatility for an individual public company within an index averaged for the past 16 quarters.
The weighted average quarterly median volatility assumption used for the warrant valuation at December 31, 2011 was 52.5 percent, compared to 50.7 percent at December 31, 2010.  ?
Actual data on cancellations and exercises of our equity warrant assets are utilized as the basis for determining the expected remaining life of the equity warrant assets in each financial reporting period.
Equity warrant assets may be exercised in the event of acquisitions, mergers or IPOs, and cancelled due to events such as bankruptcies, restructuring activities or additional financings.
These events cause the expected remaining life assumption to be shorter than the contractual term of the warrants.  ?
The risk-free interest rate is derived from the Treasury yield curve and is calculated based on a weighted average of the riskfree interest rates that correspond closest to the expected remaining life of the warrant.
The risk-free interest rate used for the warrant valuation at December 31, 2011 was 0.4 percent, compared to 1.0 percent at December 31, 2010.  ?
Other adjustments, including a lack of marketability discount, are estimated based on management’s judgment about the general industry environment.
The fair value of our equity warrant assets recorded on our balance sheets represents our best estimate of the fair value of these instruments.
Changes in the above inputs may result in significantly different valuations.
For example, the following table demonstrates the effect of changes in the risk-free interest rate and volatility assumptions on the valuation of equity warrant assets directly held by SVB Financial Group at December 31, 2011:
## Table 2 ##
The timing and value realized from the disposition of equity warrant assets depend upon factors beyond our control, including the performance of the underlying portfolio companies, investor demand for IPOs, fluctuations in the market prices of the underlying common stock of these companies, levels of M&A activity, and legal and contractual restrictions on our ability to sell the underlying securities.
All of these factors are difficult to predict.
Many equity warrant assets may be terminated or may expire without compensation and may incur valuation losses from lower-priced funding rounds.
We are unable to predict future gains or losses with accuracy, and gains or losses could vary materially from period to period.
We consider our accounting policy for equity warrant assets to be critical as the valuation of these assets is complex and subject to a certain degree of management judgment.
Management has the ability to select from several valuation techniques and has alternative approaches in the calculation of significant inputs.
The
Table of Contents Credit Quality and Allowance for Loan Losses The following table presents a summary of the activity for the allowance for loan losses as of the five most recent year-ends:
## Table 3 ##
The following table summarizes the allocation of the allowance for loan losses among specific classes of loans as of the five most recent year-ends:
## Table 4 ##
(1) Represents loan category as a percentage of total gross loans as of year end.

Tables referenced above, in order (Table 0 first):
<table><tr><td>Current assets</td><td>$1,922</td></tr><tr><td>Long-term assets</td><td>253</td></tr><tr><td>Identifiable intangible assets</td><td>5,005</td></tr><tr><td>Total liabilities assumed</td><td>-3,279</td></tr><tr><td>Total identifiable net assets</td><td>3,901</td></tr><tr><td>Goodwill</td><td>6,099</td></tr><tr><td>Net assets acquired</td><td>$10,000</td></tr></table>
<table><tr><td> (Dollars in thousands)</td><td> Fair Value</td><td> Unfunded Commitments</td></tr><tr><td>Non-marketable securities (fair value accounting):</td><td></td><td></td></tr><tr><td>Venture capital and private equity fund investments -1</td><td>$611,824</td><td>$309,765</td></tr><tr><td>Non-marketable securities (equity method accounting):</td><td></td><td></td></tr><tr><td>Other investments -2</td><td>61,227</td><td>8,750</td></tr><tr><td>Non-marketable securities (cost method accounting):</td><td></td><td></td></tr><tr><td>Venture capital and private equity fund investments -3</td><td>163,674</td><td>80,010</td></tr><tr><td>Total</td><td>$836,725</td><td>$398,525</td></tr></table>
<table><tr><td></td><td colspan="3"> Volatility Factor</td></tr><tr><td> (Dollars in millions)</td><td> 10% Lower -47.3%</td><td> Current -52.5%</td><td> 10% Higher -57.8%</td></tr><tr><td> Risk free interest rate:</td><td></td><td></td><td></td></tr><tr><td>Less 50 basis points</td><td>$63.5</td><td>$66.5</td><td>$69.5</td></tr><tr><td>Current weighted average rate -0.4%</td><td>63.9</td><td>66.7</td><td>69.9</td></tr><tr><td>Plus 50 basis points</td><td>64.5</td><td>67.5</td><td>70.4</td></tr></table>
<table><tr><td></td><td colspan="5">Year ended December 31,</td></tr><tr><td> (Dollars in thousands)</td><td>2011</td><td>2010</td><td>2009</td><td>2008</td><td>2007</td></tr><tr><td>Allowance for loan losses balance, beginning of year</td><td>$82,627</td><td>$72,450</td><td>$107,396</td><td>$47,293</td><td>$42,747</td></tr><tr><td>Charge-offs:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Commercial loans:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Software</td><td>-10,252</td><td>-16,230</td><td>-38,869</td><td>-26,702</td><td>-12,088</td></tr><tr><td>Hardware</td><td>-4,828</td><td>-10,568</td><td>-58,261</td><td>-8,077</td><td>-6,044</td></tr><tr><td>Venture capital/private equity</td><td>—</td><td>—</td><td>-10,635</td><td>—</td><td>-326</td></tr><tr><td>Life science</td><td>-4,201</td><td>-17,629</td><td>-16,853</td><td>-2,725</td><td>-787</td></tr><tr><td>Premium wine</td><td>-449</td><td>-1,457</td><td>-3,107</td><td>-309</td><td>-4</td></tr><tr><td>Other</td><td>-3,954</td><td>-4,866</td><td>-2,245</td><td>-2,326</td><td>-29</td></tr><tr><td>Total commercial loans</td><td>-23,684</td><td>-50,750</td><td>-129,970</td><td>-40,139</td><td>-19,278</td></tr><tr><td>Consumer loans</td><td>-220</td><td>-489</td><td>-13,600</td><td>-7,676</td><td>-100</td></tr><tr><td>Total charge-offs</td><td>-23,904</td><td>-51,239</td><td>-143,570</td><td>-47,815</td><td>-19,378</td></tr><tr><td>Recoveries:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Commercial loans:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Software</td><td>11,659</td><td>5,838</td><td>2,284</td><td>3,931</td><td>3,253</td></tr><tr><td>Hardware</td><td>455</td><td>5,715</td><td>12,645</td><td>2,441</td><td>3,377</td></tr><tr><td>Venture capital/private equity</td><td>—</td><td>—</td><td>—</td><td>294</td><td>28</td></tr><tr><td>Life science</td><td>6,644</td><td>3,738</td><td>2,708</td><td>252</td><td>11</td></tr><tr><td>Premium wine</td><td>1,223</td><td>222</td><td>55</td><td>170</td><td>66</td></tr><tr><td>Other</td><td>471</td><td>737</td><td>413</td><td>113</td><td>353</td></tr><tr><td>Total commercial loans</td><td>20,452</td><td>16,250</td><td>18,105</td><td>7,201</td><td>7,088</td></tr><tr><td>Consumer loans</td><td>4,671</td><td>538</td><td>339</td><td>4</td><td>—</td></tr><tr><td>Total recoveries</td><td>25,123</td><td>16,788</td><td>18,444</td><td>7,205</td><td>7,088</td></tr><tr><td>Provision for loan losses</td><td>6,101</td><td>44,628</td><td>90,180</td><td>100,713</td><td>16,836</td></tr><tr><td>Allowance for loan losses balance, end of year</td><td>$89,947</td><td>$82,627</td><td>$72,450</td><td>$107,396</td><td>$47,293</td></tr></table>
<table><tr><td></td><td colspan="10"> December 31,</td></tr><tr><td></td><td colspan="2">2011</td><td colspan="2">2010</td><td colspan="2">2009</td><td colspan="2">2008</td><td colspan="2"> 2007</td></tr><tr><td> (Dollars in thousands)</td><td> ALLL Amount</td><td>Loans as Percent of Total Loans -1</td><td> ALLL Amount</td><td>Loans as Percent of Total Loans -1</td><td> ALLL Amount</td><td>Loans as Percent of Total Loans -1</td><td> ALLL Amount</td><td>Loans as Percent of Total Loans -1</td><td> ALLL Amount</td><td> Loans as Percent of Total Loans -1</td></tr><tr><td>Commercial loans:</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Software</td><td>$38,263</td><td>35.8%</td><td>$29,288</td><td>33.0%</td><td>$24,209</td><td>30.4%</td><td>$29,007</td><td>31.4%</td><td>$16,155</td><td>31.6%</td></tr><tr><td>Hardware</td><td>16,810</td><td>13.7</td><td>14,688</td><td>11.6</td><td>16,194</td><td>13.2</td><td>21,604</td><td>16.7</td><td>12,826</td><td>15.0</td></tr><tr><td>Venture capital/private equity</td><td>7,319</td><td>16.1</td><td>8,241</td><td>18.8</td><td>5,664</td><td>20.4</td><td>30,540</td><td>19.2</td><td>7,200</td><td>18.5</td></tr><tr><td>Life science</td><td>10,243</td><td>12.4</td><td>9,077</td><td>10.5</td><td>9,651</td><td>11.4</td><td>7,989</td><td>10.8</td><td>3,370</td><td>9.8</td></tr><tr><td>Premium wine</td><td>3,914</td><td>6.8</td><td>5,492</td><td>8.2</td><td>4,652</td><td>9.7</td><td>4,094</td><td>7.6</td><td>3,358</td><td>9.0</td></tr><tr><td>Other</td><td>5,817</td><td>5.3</td><td>5,318</td><td>7.9</td><td>3,877</td><td>5.3</td><td>3,717</td><td>4.9</td><td>2,289</td><td>6.5</td></tr><tr><td>Total commercial loans</td><td>82,366</td><td>90.1</td><td>72,104</td><td>90.0</td><td>64,247</td><td>90.4</td><td>96,951</td><td>90.6</td><td>45,198</td><td>90.4</td></tr><tr><td>Consumer loans</td><td>7,581</td><td>9.9</td><td>10,523</td><td>10.0</td><td>8,203</td><td>9.6</td><td>10,445</td><td>9.4</td><td>2,095</td><td>9.6</td></tr><tr><td>Total</td><td>$89,947</td><td>100.0%</td><td>$82,627</td><td>100.0%</td><td>$72,450</td><td>100.0%</td><td>$107,396</td><td>100.0%</td><td>$47,293</td><td>100.0%</td></tr></table>

Question: What is the growing rate of Total charge-offs in the years with the least Life science?
Answer: -0.53348
Reasoning program: add(-23904,51239), divide(#0,-51239)